PhoenixBio Co., Ltd. (6190.T)
JPY 335.0
(-1.76%)
JPY 335.0
(-1.76%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 11.06 Million JPY | -97.82% |
| 2022 | 508.44 Million JPY | 403.34% |
| 2021 | -167.61 Million JPY | 39.46% |
| 2020 | -276.88 Million JPY | -88.36% |
| 2019 | -147 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 5 Million JPY | 125.44% |
| 2023 Q2 | -12.11 Million JPY | -272.3% |
| 2023 Q4 | -19.65 Million JPY | -154.9% |
| 2023 Q3 | 35.8 Million JPY | 395.49% |
| 2023 FY | 11.06 Million JPY | -97.82% |
| 2023 Q1 | 7.03 Million JPY | -83.88% |
| 2022 Q2 | 278.15 Million JPY | 0.0% |
| 2022 FY | 508.44 Million JPY | 403.34% |
| 2022 Q4 | 43.62 Million JPY | -55.31% |
| 2022 Q3 | 97.61 Million JPY | -64.91% |
| 2021 FY | -167.61 Million JPY | 39.46% |
| 2020 FY | -276.88 Million JPY | -88.36% |
| 2019 FY | -147 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 98.146% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | 102.227% |
| GNI Group Ltd. | 13.1 Billion JPY | 99.916% |
| Linical Co., Ltd. | 725.72 Million JPY | 98.476% |
| Trans Genic Inc. | 89.43 Million JPY | 87.63% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 100.776% |
| Soiken Holdings Inc. | -610 Million JPY | 101.814% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | 101.432% |
| AnGes, Inc. | -11.96 Billion JPY | 100.092% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 100.987% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 100.116% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 89.393% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 101.28% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 100.99% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 100.877% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 101.385% |
| RaQualia Pharma Inc. | -337.36 Million JPY | 103.279% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 100.918% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 100.828% |
| PeptiDream Inc. | 6.77 Billion JPY | 99.837% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 100.573% |
| Ribomic Inc. | -1.11 Billion JPY | 100.991% |
| SanBio Company Limited | -4.53 Billion JPY | 100.244% |
| Healios K.K. | -3.37 Billion JPY | 100.327% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 100.958% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 100.794% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 100.789% |
| StemRIM | -2.07 Billion JPY | 100.533% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 99.094% |
| FunPep Company Limited | -994 Million JPY | 101.113% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 101.245% |
| Stella Pharma Corporation | -760.3 Million JPY | 101.455% |
| TMS Co., Ltd. | -943.25 Million JPY | 101.173% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 101.427% |
| Cuorips Inc. | -588.48 Million JPY | 101.88% |
| K Pharma,Inc. | 366.05 Million JPY | 96.978% |
| Takara Bio Inc. | 3 Billion JPY | 99.632% |
| ReproCELL Incorporated | -409.29 Million JPY | 102.703% |
| StemCell Institute Inc. | 413.75 Million JPY | 97.326% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 92.344% |
| CellSeed Inc. | -697.77 Million JPY | 101.585% |